Low early ototoxicity rates for pediatric medulloblastoma patients treated with proton radiotherapy

BACKGROUND: Hearing loss is common following chemoradiotherapy for children with medulloblastoma. Compared to photons, proton radiotherapy reduces radiation dose to the cochlea for these patients. Here we examine whether this dosimetric advantage leads to a clinical benefit in audiometric outcomes....

Full description

Saved in:
Bibliographic Details
Main Authors: Moeller, Benjamin J, Chintagumpala, Murali, Philip, Jimmy J, Grosshans, David R, McAleer, Mary F, Woo, Shiao Y, Gidley, Paul W, Vats, Tribhawan S, Mahajan, Anita
Format: Artigo
Language:Inglês
Published: BioMed Central 2011
Subjects:
Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3123575/
https://ncbi.nlm.nih.gov/pubmed/21635776
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1748-717X-6-58
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items